EBM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Eastwood Bio-Medical Canada Inc

Watchlist Manager

Watchlist

Price: 0.98 CAD 6.52%

Market Cap: CA$67.5m

	Eastwood Bio-Medical Canada Inc XTSX:EBM	CA
K	Kemper Corp F:UI2	US
S	SoftBank Group Corp DUS:SFT	JP
S	Sarepta Therapeutics Inc F:AB3A	US

Profitability Summary

Eastwood Bio-Medical Canada Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

65%

Gross Margin is Increasing

66% > 69%

Negative Operating Margin

-42%

Negative 3Y Average Operating Margin

-57%

Declining Operating Margin

-27% > -42%

Negative Net Margin

-43%

Negative 3Y Average Net Margin

-58%

Declining Net Margin

-29% > -43%

Negative Free Cash Flow Margin

-10%

Negative 3Y Average Free Cash Flow Margin

-1%

Declining Free Cash Flow Margin

-3% > -10%

Positive ROE

21%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-173%

Declining ROIC

-78% > -208%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.